CA2492248A1 - Composition and methods for the treatment of skin disorders - Google Patents

Composition and methods for the treatment of skin disorders Download PDF

Info

Publication number
CA2492248A1
CA2492248A1 CA002492248A CA2492248A CA2492248A1 CA 2492248 A1 CA2492248 A1 CA 2492248A1 CA 002492248 A CA002492248 A CA 002492248A CA 2492248 A CA2492248 A CA 2492248A CA 2492248 A1 CA2492248 A1 CA 2492248A1
Authority
CA
Canada
Prior art keywords
vitamin
metabolite
nicotinamide
cadpr
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002492248A
Other languages
English (en)
French (fr)
Inventor
Avikam Harel
Olga Bloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/192,842 external-priority patent/US20030032617A1/en
Application filed by Individual filed Critical Individual
Publication of CA2492248A1 publication Critical patent/CA2492248A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002492248A 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders Abandoned CA2492248A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/192,842 US20030032617A1 (en) 2000-01-11 2002-07-11 Composition and methods for the treatment of skin disorders
US10/192,842 2002-07-11
PCT/IL2003/000576 WO2004006887A2 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
CA2492248A1 true CA2492248A1 (en) 2004-01-22

Family

ID=30114413

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002492248A Abandoned CA2492248A1 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders

Country Status (4)

Country Link
EP (1) EP1539100A4 (de)
AU (1) AU2003242965B2 (de)
CA (1) CA2492248A1 (de)
WO (1) WO2004006887A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120681A2 (en) 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for skin care
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CA2569279A1 (en) * 2004-06-04 2005-12-15 Chemgenex Pharmaceuticals, Inc. Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors
BRPI0609630A2 (pt) 2005-05-10 2010-04-20 Dermipsor Ltd composições e métodos para tratamento de doenças epidérmicas hiperproliferativas
US9877981B2 (en) 2012-10-09 2018-01-30 President And Fellows Of Harvard College NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
CN108836965A (zh) * 2018-08-07 2018-11-20 浙江大学 尼克酰胺组合物在制备治疗索拉非尼手足皮肤反应药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US5831074A (en) * 1988-11-02 1998-11-03 Strumwasser; Felix Eucaryotic NAD cyclases
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin- und -mineralpräparat
IL133976A (en) * 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders

Also Published As

Publication number Publication date
WO2004006887A2 (en) 2004-01-22
WO2004006887A3 (en) 2004-03-18
AU2003242965B2 (en) 2009-02-05
EP1539100A4 (de) 2006-01-18
AU2003242965A1 (en) 2004-02-02
EP1539100A2 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
US20030032617A1 (en) Composition and methods for the treatment of skin disorders
DK1879595T3 (en) Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
NZ248069A (en) Topical liquid composition for skin application comprising retinoic acid or an ester for treating dermatological disorders, together with alpha tocopherol to reduce skin irritation
EA032660B1 (ru) Композиции, включающие акампросат, баклофен и леводопу, для лечения паркинсонизма
EP3288531A1 (de) Verfahren zur verbesserung der hautgesundheit und zusammensetzungen dafür
PL182597B1 (pl) Kompozycja farmaceutyczna i kosmetyczna do modyfikowania apoptozy
AU2003242965B2 (en) Composition and methods for the treatment of skin disorders
AU762364B2 (en) Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
Liang et al. The regulation of dopamine release from striatum slices by tetrahydrobiopterin and L-arginine-derived nitric oxide
US20160220589A1 (en) Compositions and methods for the treatment of skin disorders
Dalpiaz et al. Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate
IE64186B1 (en) Dehydrocholecalciferol derivatives
KR20130120450A (ko) 광 노출에 의한 비정상적인 피부 세포 형성 억제제
US20220249404A1 (en) Composition containing fluoxetine and vitamin d3 or its derivatives, and application thereof
IL150706A (en) Combinations of nicotinamide and vitamin d agents and use thereof in preparation of compositions for the treatment of skin disorders
US20200397745A1 (en) Composition for inhibiting skin cell proliferation and/or anti-inflammation method for inhibiting skin cell proliferation and/or anti-inflammation and method for treating skin diseases and/or inflammatory diseases
US5618545A (en) Skin-cosmetic composition
CN116350531A (zh) 猫眼草酚d的抗糖化应用
CN116459172A (zh) 蔓荆子黄素的抗糖化应用
US20220211605A1 (en) Agent for protection against atmospheric pollutants and composition for protection against atmospheric pollutants
Burstein Prostaglandins and Cannabis—IV: A Biochemical Basis for Therapeutic Applications
US20030113281A1 (en) Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
JPH04356425A (ja) ウイルス・ゲノム不活化−発がんプロモーション阻害剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140312